Cue Biopharma
CUE | NASDAQ
$14.10
-$2.02 (-12.53%)
At close: Nov 16, 2026, 4:00 PM ET
$13.80
-$0.30 (-2.13%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-12.53%
(1D)No price chart data available for 1D timeframe.
Rating
52
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #238/1021 (Top 23%)
Key Statistics
Market Data
Market Cap $102.43M
1D Range
13.56 15.81
52W Range
5.31 37.84
Valuation (TTM)
PE -0.52
PB 44.34
EV/EBITDA -0.98
Valuation (NTM)
Forward PE N/A
Forward PEG -0.01
Price Target $83.00
Cash Flow
FCF Yield -49.0%
SBC Adj. FCF Yield -74.4%
SBC Impact -51.9%
Margins
Gross Margin 99.7%
Operating Margin -262.0%
FCF Margin -133.2%
Growth (CAGR)
Revenue 3Y | 5Y 176.2% |
47.1%
Dil EPS 3Y | 5Y 4.3% |
18.4%
FCF 3Y | 5Y -14.8% |
-1.6%
Returns
ROA -534.4%
ROE -1032.2%
ROIC -887.3%
Financial Health
Net Cash
$11.66M
Current Ratio 1.25
Interest Coverage -730.70
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Cue Biopharma, Inc. is a clinical-stage biopharmaceutical enterprise focused on creating biological therapies. Its central objective is the precise manipulation of the human immune system to address a...
Sector Healthcare
Industry Biotechnology
Employees 29
IPO Date Jan 2, 2018
Website www.cuebiopharma.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove CUE